Comparison of PolarX and the Arctic Front Cryoballoons for PVI in Patients With Symptomatic Paroxysmal AF

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

March 29, 2021

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2025

Conditions
Paroxysmal Atrial Fibrillation
Interventions
DEVICE

PVI using the Arctic Front Cryoballoon (Medtronic)

"Patients randomized to the Arctic Front cryoballoon group will undergo PVI using the Arctic Front Cryoballoon (Medtronic).~At the end of the procedure, an implantable cardiac monitor (Medtronic Reveal LINQ) will be implanted for the purpose of continuous arrhythmia monitoring."

DRUG

PVI using the PolarX Cryoballoon (Boston Scientific)

"Patients randomized to PolarX cryoballoon group will undergo PVI using the PolarX Cryoballoon (Boston Scientific).~At the end of the procedure, an implantable cardiac monitor (Medtronic Reveal LINQ) will be implanted for the purpose of continuous arrhythmia monitoring."

Trial Locations (2)

3010

Inselspital, Bern University Hospital, Bern

4031

University Hospital Basel, Basel

All Listed Sponsors
collaborator

University Hospital, Basel, Switzerland

OTHER

lead

Insel Gruppe AG, University Hospital Bern

OTHER